BiotechTube
Trace Orthopedics

Trace Orthopedics

Austin, United States· Est.
traceorthopedics.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.5M

Overview

Trace Orthopedics is an early-stage, private medical device company founded in 2019 and headquartered in Austin, Texas, with an operational office in Philadelphia. The company is developing a percutaneous tendon-to-bone anchor system to treat partial tendon tears, such as those in the gluteus medius of the hip, without the need for surgery. Led by a team with expertise in biomedical engineering and musculoskeletal radiology, the company is in the pre-clinical, pre-revenue stage, actively raising capital via SAFE notes to fund product development and FDA clearance. Their innovation targets a significant patient population undergoing surgical repair, promising a faster, lower-cost alternative.

OrthopedicsSports Medicine

Technology Platform

Percutaneous tendon-to-bone anchor system delivered via a needle for minimally invasive tendon repair, utilizing a steerable needle for precise placement.

Funding History

1
Total raised:$2.5M
Seed$2.5M

Opportunities

The technology addresses a large, underserved market of partial tendon tears, potentially preventing progression to full tears and capturing patients currently managed only with conservative care.
Shifting procedures from the OR to an outpatient setting offers a compelling value-based care proposition by significantly reducing healthcare costs and patient recovery time.

Risk Factors

Key risks include unproven long-term biomechanical performance and healing in a clinical setting, a potentially lengthy and costly FDA regulatory pathway for a novel device, and the significant challenge of driving adoption among traditionally trained orthopedic surgeons.
The company's reliance on ongoing fundraising creates financial and dilution risk.

Competitive Landscape

Direct competition for a percutaneous tendon repair device appears limited, positioning Trace as a pioneer. However, they face indirect competition from established surgical techniques (open and arthroscopic repair using suture anchors) and conservative management. Large orthopedic device companies (e.g., Arthrex, Stryker, Smith & Nephew) dominate the traditional repair market and could develop or acquire competing technologies.

More companies in Regenerative Medicine →More companies in United States →